The University of Toledo and the American Cancer Society are teaming up to encourage participation in the latest phase of a national cancer study that will provide new understanding about the causes of the disease.
Dr. Roland Skeel, UT professor of medicine, was interviewed by WTOL News 11 after a press conference last week to announce the University and the American Cancer Society are partnering for a research study.
“The past decade has seen an explosion of new knowledge about cancer that has shown great promise for our ability to control this often devastating health problem,” said Dr. Roland T. Skeel, UT professor of medicine. “While new, more targeted and individualized treatments have improved our ability to fight against cancer, this study to improve our understanding of the causes of cancer can do even more to help reduce the number of lives impacted by this disease.”
“The Cancer Prevention Study has revealed incredibly important things about the relationship between human behaviors and cancer,” said Toledo Mayor Mike Bell. “I am very excited about this partnership with the American Cancer Society, The University of Toledo and the city of Toledo that empowers our citizens to be proactive in the fight against cancer.”
The study is open to anyone between the ages of 30 and 65 who has never been diagnosed with cancer. The University’s goal is to enroll 800 adults from various racial and ethnic backgrounds in northwest Ohio to collect data that may one day help eliminate cancer as a major health risk.
The first step will take place at UT enrollment sites, scheduled on Main and Health Science campuses from Tuesday, April 16, through Saturday, April 20. Participants will be asked to read and sign a consent form, complete a small written survey, and provide a waist circumference and a small blood sample.
Additional steps will occur at home. Participants will be asked to complete ongoing surveys that will include questions about factors related to their health. These surveys will be mailed periodically over the span of the research study.
For more information or to register to participate, visit ToledoCPS3.org or contact Andrew Mariani at 888.227.6446 extension 5103 or andrew.mariani@cancer.org.
